RetroSense Using Optogenetics to Treat Retinitis Pigmentosa and Dry AMD

Here is an article from Eye Doc News, a website run by 2 ophthalmologists, Dr.  Ari Weitzner and Dr. Dominique Walton Brooks. 

RetroSense Therapeutics is a biotechnology company using optogenetic approaches to treat retinal diseases such as retinitis pigmentosa and dry AMD.

Optogenetics refers to a technique for restoring vision that uses “opsins” to genetically convert retinal cells that were not previously, or natively light sensitive to become light sensitive, and thereby mimic the function of rods and cones.

For example, patients with retinitis pigmentosa experience progressive and irreversible vision loss because the rods and cones of their eyes die. Retrosense’s technique allows other cells in the retina (e.g., ganglion cells) to take the place of the rods and cones.

For more info, go here: http://irvaronsjournal.blogspot.com/2013/03/gene-therapy-in-ophthalmology-update-18.html

Like all genetic treatments, this should be approached with a skeptical optimism.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: